Figure 4From: Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12–24 monthsThe pattern of cytophilic to non-cytophilic ratio. Line with filled squares show children vaccinated with 15 μg MSP3, filled circle show children vaccinated with 30 μg MSP3 and filled triangle show children vaccinated with Engerix B. Error bars show 95% confidence interval.Back to article page